Acinetobacter Pneumonia: A Review

Joshua D. Hartzell, MD, Andrew S. Kim, MD, Mark G. Kortepeter, MD, MPH, Kimberly A. Moran, MD

In This Article


Abc pneumonia is an emerging cause of nosocomial pneumonia, and multidrug resistance makes treatment a major challenge. Early recognition and appropriate antibiotic therapy based on culture and susceptibility data are necessary to obviate poor outcomes and prevent increasing resistance. There are several areas where future research is needed ( Table 2 ), including the pressing need for effective infection control strategies and development of new antimicrobials against gram-negative bacteria.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.